AN2 Therapeutics ANTX
NASDAQ ANTX
$5.09 +0.08 (+1.60%)
At close: Sep 29, 2026 · 4:00 PM EDT

AN2 Therapeutics (ANTX) Restructuring Costs (2024)

Updated

AN2 Therapeutics (ANTX) recorded Restructuring Costs of -$9,000 in Q4 2024.

Analysis

AN2 Therapeutics (ANTX) Restructuring Costs (2024) Analysis & Trends

For FY2024, AN2 Therapeutics reported Restructuring Costs of $2.23 million.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn
10 AN2 Therapeutics 181.91 Mn 181.91 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 -9,000.00
Sep 30, 2024 2.24 Mn
API Access

AN2 Therapeutics Restructuring Costs API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=restructuring-costs&ticker=ANTX&period=max&api_key=YOUR_API_KEY